A clinical assessment, based on the information available, was able to find evidence to support the following reported events: right iliac stent collapse, claudication, near occlusion, dissection, non-endologix stent placement, and deep vein thrombus status post evar procedure.At eight months post-implant, the most likely cause for the right iliac stent collapse was anatomy related.The iliac artery was very tortuous and diseased, with development of a right dissection - a cautionary product use condition.The iliac artery also had a greater than 90° posterior angulation - an off-label anatomy.The inferior stent margin of first the original right iliac portion of the main body stent was sub-optimally positioned whereby the inferior margin was near perpendicular to the vessel wall; an anatomy related issue.There was no user error detected.The pre-existing patient conditions that contributed to near occlusive right iliac included: a new right iliac dissection, concomitant treatment for cancer, and continued use of tobacco products.Associated clinical harms for this device failure included: near complete thrombus occlusion of the right iliac artery, claudication, medical management and endovascular relining on the right iliac artery and stent, as well as a procedure-related deep vein thrombus.The review of manufacturing lot information confirmed all devices met specifications prior to release.This complaint is not capa eligible at this time.These types of events will be monitored and trended as part of the quality system.
|